Accendra Health, Inc., formerly known as Owens & Minor, Inc., reported a net revenue of $2.76 billion for the fiscal year ending December 31, 2025, reflecting a 3.1% increase from $2.68 billion in 2024. The company experienced a net loss per share from continuing operations of $(1.34), an improvement from a loss of $(4.57) in the previous year. This positive shift was attributed to several factors, including the absence of goodwill impairment charges, which had significantly impacted the prior year's results, and a reduction in exit and realignment charges. The company also noted a revenue growth of $82 million, driven by increased sales in key product categories such as sleep therapy and ostomy care.
A significant strategic development for Accendra Health was the completion of the sale of its Products & Healthcare Services (P&HS) business for $375 million in cash on December 31, 2025. This divestiture has resulted in the company becoming a more focused entity, concentrating on its core operations in home healthcare. Following the sale, Accendra retained a 5% equity interest in the P&HS business. The company anticipates that this strategic move will allow it to direct capital towards higher growth and margin opportunities within its remaining business segments.
Operationally, Accendra Health reported a reduction in its employee headcount to over 6,500 following the sale of the P&HS business. The company has emphasized its commitment to maintaining a results-driven culture and has implemented various initiatives to attract and retain talent. The company also reported a significant decrease in accounts receivable, down 56.1% to $95.9 million, which contributed to a reduction in days sales outstanding (DSO) to 12.4 days, indicating improved efficiency in collections.
Looking ahead, Accendra Health faces challenges, including the termination of contracts with a major commercial payor, which accounted for approximately 12% of its net revenue. The company is actively working to mitigate the impact of this loss by seeking new business opportunities and optimizing operational efficiencies. Additionally, the company is navigating a competitive landscape characterized by pricing pressures and evolving market conditions. Accendra Health's management remains focused on leveraging its core competencies to drive growth and enhance shareholder value in the coming fiscal periods.
About OWENS & MINOR INC/VA/
Owens & Minor, Inc. is a global healthcare solutions provider specializing in product manufacturing, distribution, and technology services. It serves healthcare providers worldwide with medical supplies, surgical products, and clinical support, focusing on infection prevention and home healthcare. The company operates through two segments: Products & Healthcare Services and Patient Direct, emphasizing quality, innovation, and cost efficiency across the healthcare supply chain.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.